{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:24:28Z","timestamp":1787037868416,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02937-w","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:02:37Z","timestamp":1780470157000},"page":"1881-1888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aldosterone-related biochemical phenotypes in adrenal incidentalomas: clinical relevance in a cohort including normotensive patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Cindy","family":"Idrobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Mart\u00edn","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Aguilar-Monserrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2937_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am J Roentgenol 190:1163\u20131168. https:\/\/doi.org\/10.2214\/AJR.07.2799","journal-title":"Am J Roentgenol"},{"key":"2937_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/EJENDO\/LVAD066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J et al (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 189:G1\u201342. https:\/\/doi.org\/10.1093\/EJENDO\/LVAD066","journal-title":"Eur J Endocrinol"},{"key":"2937_CR3","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/CLINEM\/DGAF284","volume":"110","author":"GK Adler","year":"2025","unstructured":"Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ et al (2025) Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 110:2453\u20132495. https:\/\/doi.org\/10.1210\/CLINEM\/DGAF284","journal-title":"J Clin Endocrinol Metab"},{"key":"2937_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH et al (2020) The unrecognized prevalence of primary aldosteronism a cross-sectional study. Ann Intern Med 173:10\u201320. https:\/\/doi.org\/10.7326\/M20-0065","journal-title":"Ann Intern Med"},{"key":"2937_CR5","doi-asserted-by":"publisher","unstructured":"Kmie\u0107 P, Zalewska E, Kunicka K, \u015awierblewska E, Sworczak K Autonomous Aldosterone Secretion in Patients with Adrenal Incidentaloma. Biomedicines 2022;10. https:\/\/doi.org\/10.3390\/BIOMEDICINES10123075","DOI":"10.3390\/BIOMEDICINES10123075"},{"key":"2937_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/S12020-007-9028-8","volume":"32","author":"M Tzanela","year":"2007","unstructured":"Tzanela M, Effremidis G, Vassiliadi D, Szabo A, Gavalas N, Valatsou A et al (2007) The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses. Endocrine 32:136\u2013142. https:\/\/doi.org\/10.1007\/S12020-007-9028-8","journal-title":"Endocrine"},{"key":"2937_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1055\/s-2007-973058","volume":"115","author":"H Vierhapper","year":"2007","unstructured":"Vierhapper H (2007) Determination of the aldosterone\/renin ratio in 269 patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes 115:518\u2013521. https:\/\/doi.org\/10.1055\/s-2007-973058","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2937_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5159382","volume":"2017","author":"X Lin","year":"2017","unstructured":"Lin X, Miao X, Zhu P, Lin F (2017) A Normotensive Patient with Primary Aldosteronism. Case Rep Endocrinol 2017:1\u20134. https:\/\/doi.org\/10.1155\/2017\/5159382","journal-title":"Case Rep Endocrinol"},{"key":"2937_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ et al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243\u20131248. https:\/\/doi.org\/10.1016\/j.jacc.2005.01.015","journal-title":"J Am Coll Cardiol"},{"key":"2937_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi GL, Nadalini E, Chiuch A, Baroselli S, Lapenna R et al (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168:80\u201385. https:\/\/doi.org\/10.1001\/archinternmed.2007.33","journal-title":"Arch Intern Med"},{"key":"2937_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.108.816108","volume":"119","author":"W Lieb","year":"2009","unstructured":"Lieb W, Larson MG, Benjamin EJ, Yin X, Tofler GH, Selhub J et al (2009) Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 119:37\u201343. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.816108","journal-title":"Circulation"},{"key":"2937_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/S12020-011-9553-3","volume":"41","author":"N Sukor","year":"2012","unstructured":"Sukor N (2012) Primary aldosteronism: from bench to bedside. Endocrine 41:31\u201339. https:\/\/doi.org\/10.1007\/S12020-011-9553-3","journal-title":"Endocrine"},{"key":"2937_CR13","doi-asserted-by":"publisher","unstructured":"Jia G, Habibi J, Aroor AR, Hill MA, Yang Y, Whaley-Connell A et al (2018) Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction. Hypertens (Dallas, Tex 1979. 72:731\u2013738. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11339","DOI":"10.1161\/HYPERTENSIONAHA.118.11339"},{"key":"2937_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa033263","volume":"351","author":"RS Vasan","year":"2004","unstructured":"Vasan RS, Evans JC, Larson MG, Wilson PWF, Meigs JB, Rifai N et al (2004) Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons. N Engl J Med 351:33\u201341","journal-title":"N Engl J Med"},{"key":"2937_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/JHH.2008.27","volume":"22","author":"P Meneton","year":"2008","unstructured":"Meneton P, Galan P, Bertrais S, Heudes D, Hercberg S, M\u00e9nard J (2008) High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations. J Hum Hypertens 22:550\u2013558. https:\/\/doi.org\/10.1038\/JHH.2008.27","journal-title":"J Hum Hypertens"},{"key":"2937_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","volume":"126","author":"R Kreutz","year":"2024","unstructured":"Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML et al (2024) 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med 126:1\u201315. https:\/\/doi.org\/10.1016\/j.ejim.2024.05.033","journal-title":"Eur J Intern Med"},{"key":"2937_CR17","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC et al (2020) Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens 38:1919\u20131928. https:\/\/doi.org\/10.1097\/HJH.0000000000002510","journal-title":"J Hypertens"},{"key":"2937_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s40618-023-02283-1","volume":"47","author":"I Bonaventura","year":"2024","unstructured":"Bonaventura I, Tomaselli A, Angelini F, Ferrari D, De Alcubierre D, Hasenmajer V et al (2024) Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study. J Endocrinol Invest 47:1751\u20131762. https:\/\/doi.org\/10.1007\/s40618-023-02283-1","journal-title":"J Endocrinol Invest"},{"key":"2937_CR19","doi-asserted-by":"publisher","unstructured":"Hu J, Shen H, Huo P, Yang J, Fuller PJ, Wang K et al Heightened Cardiovascular Risk in Hypertension Associated With Renin-Independent Aldosteronism Versus Renin-Dependent Aldosteronism: A Collaborative Study. J Am Heart Assoc 2021;10. https:\/\/doi.org\/10.1161\/JAHA.121.023082","DOI":"10.1161\/JAHA.121.023082"},{"key":"2937_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/17446651.2025.2480704","volume":"20","author":"MB Iriarte-Dur\u00e1n","year":"2025","unstructured":"Iriarte-Dur\u00e1n MB, Donato S, Herrera A, Vega A, Jim\u00e9nez Casinello JM, Marazuela M et al (2025) The impact of mild autonomous cortisol secretion and proposed interventions. Expert Rev Endocrinol Metab 20:251\u2013266. https:\/\/doi.org\/10.1080\/17446651.2025.2480704","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2937_CR21","doi-asserted-by":"publisher","unstructured":"Araujo-Castro M, Reincke M, Lamas C Epidemiology and Management of Hypertension and Diabetes Mellitus in Patients with Mild Autonomous Cortisol Secretion: A Review. Biomedicines 2023;11. https:\/\/doi.org\/10.3390\/BIOMEDICINES11123115","DOI":"10.3390\/BIOMEDICINES11123115"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02937-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02937-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02937-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:29:26Z","timestamp":1787034566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02937-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02937-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Hospital Universitario Ram\u00f3n y Cajal. Madrid. Spain (approval date: February 14 of 2019, ADRENAL-INCIDENTALOMA database). Informed Consent Statement: Patient consent was waived due to the retrospective nature of the study. Only patients who continued to follow up or prospectively included the informed consent were requested.","order":2,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}